HEG Limited faces a critical Q1 FY27 as it balances a major demerger process against the backdrop of persistent logistical disruptions in the Middle East. Investors will be focused on whether the company's EBITDA margin hit the guided 20% mark and if global price increases are finally gaining traction for its graphite electrode business.
| Results date | July 22, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 603 Cr |
| Previous quarter PAT | -Rs. 163.19 Cr |
| Previous quarter EBITDA margin | Negative due to fair-value loss |
| Market cap | Rs. 11,354.79 Cr |
| CMP | Rs. 588.4 |
The board meeting is scheduled for July 22, 2026, to approve the unaudited Q1 FY27 results.
Management has guided for an EBITDA margin of approximately 20% for the first two quarters of FY27, a target that remains the primary benchmark for this print following the disruptions seen in Q4 FY26. While needle coke supply costs are locked under fixed-price contracts through September 2026, the ongoing Strait of Hormuz geopolitical tensions continue to pose a headwind for the ~20% of sales typically destined for the Middle East. Global steel production trends remain mixed, with India's output growing 7.8% YoY through May 2026, which may provide some support against the soft ex-China demand environment. Investors should look for updates on whether uncommitted volume pricing has begun to reflect the $600–$1,200 per ton increases announced by competitors earlier this year. The upcoming call will likely focus on the status of the demerger process following the NCLT order reservation on July 2, 2026, and the progress of the TACC anode project construction.
Performance vs Guidance Tracking
Graphite Electrode Pricing & Volume
Demerger & Strategic Execution
The negative EBITDA was primarily attributed to a fair-value loss on the company's investment in GrafTech, rather than operational performance. The company's underlying operational EBITDA margin remained positive during the period.
The Composite Scheme of Arrangement has received overwhelming support from shareholders and creditors. The NCLT, Indore Bench, reserved its order on the petition on July 2, 2026, and management expects the process to conclude in Q2 FY27.
Needle coke supply is secured through fixed-price contracts that remain in effect through September 2026. Management conducted contract negotiations in mid-June 2026 to determine the price trajectory for the period following September.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now